Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications
Molecules · 2023
DOI: 10.3390/molecules28135246 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Mateusz Kciuk und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biotechnology and Genetics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland. Hauptthemen laut MEDLINE: Neoplasms, Catechin. Die Arbeit wurde bisher 142-mal zitiert (Crossref) und nennt 379 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prince Sattam Bin Abdulaziz University, University of Lodz.
Abstract (Originalsprache)
Cellular signaling pathways involved in the maintenance of the equilibrium between cell proliferation and apoptosis have emerged as rational targets that can be exploited in the prevention and treatment of cancer. Epigallocatechin-3-gallate (EGCG) is the most abundant phenolic compound found in green tea. It has been shown to regulate multiple crucial cellular signaling pathways, including those mediated by EGFR, JAK-STAT, MAPKs, NF-κB, PI3K-AKT-mTOR, and others. Deregulation of the abovementioned pathways is involved in the pathophysiology of cancer. It has been demonstrated that EGCG may exert anti-proliferative, anti-inflammatory, and apoptosis-inducing effects or induce epigenetic changes. Furthermore, preclinical and clinical studies suggest that EGCG may be used in the treatment of numerous disorders, including cancer. This review aims to summarize the existing knowledge regarding the biological properties of EGCG, especially in the context of cancer treatment and prophylaxis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biotechnology and Genetics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland.
- Doctoral School of Exact and Natural Sciences, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland.
- Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, India.
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
- Department of Pharmacology & Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Al-Kharj 11942, Saudi Arabia.
- Department of Medical Biochemistry, Medical University of Lodz, Mazowiecka 6/8, 90-001 Lodz, Poland.
ORCID-Profile: Mateusz Kciuk, Nemat Ali, Ismail Celik, Esam Bashir Yahya, Renata Kontek
Förderung
- Prince Sattam Bin Abdulaziz University
- University of Lodz
Zitieren
APA
Kciuk, M., Alam, M., Ali, N., Rashid, S., Głowacka, P., Sundaraj, R., Celik, I., Yahya, E. B., Dubey, A., Zerroug, E., & Kontek, R. (2023). Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications. Molecules. https://doi.org/10.3390/molecules28135246
Vancouver
Kciuk M, Alam M, Ali N, Rashid S, Głowacka P, Sundaraj R, et al. Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications. Molecules. 2023. doi:10.3390/molecules28135246
BibTeX
@article{Kciuk2023,
author = {Kciuk, Mateusz and Alam, Manzar and Ali, Nemat and Rashid, Summya and Głowacka, Pola and Sundaraj, Rajamanikandan and Celik, Ismail and Yahya, Esam Bashir and Dubey, Amit and Zerroug, Enfale and Kontek, Renata},
title = {Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28135246}
}
EUVIMED